The impact of warfarin on the rate of progression of aortic stiffness in hemodialysis patients: A longitudinal study

Nephrology Dialysis Transplantation

Volumn 29, Issue 11, 2014, Pages 2113-2120

  Mac Way, Fabrice ^a,b   Poulin, Aurélie ^a,b   Utescu, Mihai Silviu ^a,b   De Serres, Sacha A ^a,b   Marquis, Karine ^a   Douville, Pierre ^b,c   Desmeules, Simon ^a,b   Larivière, Richard ^a,b   Lebel, Marcel ^b   Agharazii, Mohsen ^a,b  

^a Université Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Aortic stiffness; Chronic kidney disease; Mortality; Vitamin K; Warfarin

Indexed keywords

ALBUMIN; WARFARIN; ANTICOAGULANT AGENT;

AGE; AGED; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CAROTID ARTERY PULSE; CAROTID FEMORAL ARTERY PULSE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; LONGITUDINAL STUDY; MALE; MORTALITY RISK; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SURVIVAL RATE; UREMIA; VITAMIN K DEFICIENCY; CANADA; CARDIOVASCULAR DISEASES; COMPLICATION; DRUG EFFECTS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PULSE WAVE; RENAL REPLACEMENT THERAPY; RISK FACTOR; THORACIC AORTA; TIME; TRENDS;

AGED; ANTICOAGULANTS; AORTA, THORACIC; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; QUEBEC; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; VASCULAR STIFFNESS; WARFARIN;

EID: 84924348276     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu224     Document Type: Article

References (39)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(Suppl 3):S112-S119
2. Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-2439
3. Guerin AP, Blacher J, Pannier B et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001;103:987-992
4. Verbeke F, Van Biesen W, Honkanen E et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 2011;6:153-159
5. Karras A, Haymann JP, Bozec E et al. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension 2012;60:1451-1457
6. Guerin AP, London GM, Marchais SJ et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014-1021
7. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-942
8. Sigrist MK, Taal MW, Bungay P et al. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007;2:1241-1248
9. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000;87:E10-E17
10. Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81
11. Price PA, Williamson MK. Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. J Biol Chem 1985;260:14971-14975
12. Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med 2013;19:217-226
13. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998;18:1400-1407
14. Schurgers LJ, Spronk HM, Soute BA et al. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007;109:2823-2831
15. Essalihi R, Dao HH, Yamaguchi N et al. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertens 2003;16:103-110
16. Holden RM, Morton AR, Garland JS et al. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010;5:590-597
17. Rennenberg RJ, van Varik BJ, Schurgers LJ et al. Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood 2010;115:5121-5123
18. Koos R, Mahnken AH, Muhlenbruch G et al. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol 2005;96:747-749
19. Ing SW, Mohler Iii ER, Putt ME et al. Correlates of valvular ossification in patients with aortic valve stenosis. Clin Transl Sci 2009;2:431-435
20. Koos R, Krueger T, Westenfeld R et al. Relation of circulating Matrix Gla-protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost 2009;101:706-713
21. Lerner RG, Aronow WS, Sekhri A et al. Warfarin use and the risk of valvular calcification. J Thromb Haemost 2009;7:2023-2027
22. Yamamoto K, Yamamoto H, Yoshida K et al. Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis. Hypertens Res 2010;33:269-274
23. Krishnan S, Chawla N, Ezekowitz MD et al. Warfarin therapy and systolic hypertension in men with atrial fibrillation. Am J Hypertens 2005;18(12 Pt 1):1592-1599
24. Lim MA, Shafique S, See SY et al. Effects of warfarin on blood pressure in men with diabetes and hypertension-a longitudinal study. J Clin Hypertens (Greenwich) 2007;9:256-258
25. Utescu MS, Couture V, Mac-Way F et al. Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study. Hypertension 2013;62:154-160
26. Mattu GS, Perry TL, Jr, Wright JM. Comparison of the oscillometric blood pressure monitor (BPM-100 (Beta)) with the auscultatory mercury sphygmomanometer. Blood Press Monit 2001;6:153-159
27. Asmar R, Benetos A, Topouchian J et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995;26:485-490
28. Ignace S, Utescu MS, De Serres SA et al. Age-related and blood pressureindependent reduction in aortic stiffness after kidney transplantation. J Hypertens 2011;29:130-136
29. Chen CH, Nevo E, Fetics B et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure-validation of generalized transfer function. Circulation 1997;95:1827-1836
30. O'Young J, Liao Y, Xiao Y et al. Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J Am Chem Soc 2011;133:18406-18412
31. Wallin R, Cain D, Hutson SM et al. Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb Haemost 2000;84:1039-1044
32. McCabe KM, Booth SL, Fu X et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 2013;83:835-844
33. Laurent S, Cockcroft J, Van Bortel L et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588-2605
34. U. S. Renal Data System. USRDS 2011: Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2011
35. Canadian Institute for Health Information. Canadian Organ Replacement Register. Annual Report: Treatment of End-Stage Organ Failure in Canada, 2002 to 2011. Ottawa, ON: CIHI; 2012
36. Bouvet C, Peeters W, Moreau S et al. A new rat model of diabetic macrovascular complication. Cardiovasc Res 2007;73:504-511
37. Kruger T, Oelenberg S, Kaesler N et al. Warfarin induces cardiovascular damage in mice. Arterioscler Thromb Vasc Biol 2013;33:2618-2624
38. Beazley KE, Deasey S, Lima F et al. Transglutaminase 2-mediated activation of beta-catenin signaling has a critical role in warfarininduced vascular calcification. Arterioscler Thromb Vasc Biol 2012;32:123-130
39. Beazley KE, Eghtesad S, Nurminskaya MV. Quercetin attenuates warfarininduced vascular calcification in vitro independently from Matrix Gla protein. J Biol Chem 2013;288:2632-2640